BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27275098)

  • 1. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.
    Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ
    World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer.
    Tian W; Jia Y; Yuan K; Huang L; Nadolny C; Dong X; Ren X; Liu J
    Helicobacter; 2014 Feb; 19(1):9-16. PubMed ID: 24118166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Helicobacter pylori FliD antibody and the risk of gastric cancer.
    Li H; Zhang B; Hu X; Dong Y; Fan Q; Guo F; Ren X; Zhou H; Tian W; Zhao Y
    Oncotarget; 2016 Apr; 7(16):22397-408. PubMed ID: 26968951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
    Hamashima C; Sasazuki S; Inoue M; Tsugane S;
    BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries.
    Zhao Z; Li Y; Liu S; Fu W
    Tumour Biol; 2014 Dec; 35(12):12217-24. PubMed ID: 25168369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to a 26-kDa protein, alkyl hydroperoxide reductase, in Helicobacter pylori-infected Mongolian gerbil model.
    Yan J; Kumagai T; Ohnishi M; Ueno I; Ota H
    Helicobacter; 2001 Dec; 6(4):274-82. PubMed ID: 11843959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer.
    Wang XQ; Terry PD; Cheng L; Yan H; Wang JS; Wu WA; Hu SK
    World J Gastroenterol; 2014 Jul; 20(25):8151-7. PubMed ID: 25009387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
    Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of polyclonal antibody against alkyl hydroperoxide reductase of Helicobacter pylori and its antigenicity.
    Mohammadian T; Doosti M; Paknejad M; Siavoshi F; Massarrat S; Soukhtanloo M
    Hybridoma (Larchmt); 2008 Dec; 27(6):481-5. PubMed ID: 19108621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.
    Gao L; Michel A; Weck MN; Arndt V; Pawlita M; Brenner H
    Cancer Res; 2009 Aug; 69(15):6164-70. PubMed ID: 19602590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.
    Shiota S; Yamaoka Y
    Biomark Med; 2014; 8(9):1127-37. PubMed ID: 25402582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort.
    Yang JJ; Yang JH; Kim J; Ma SH; Cho LY; Ko KP; Shin A; Choi BY; Kim HJ; Han DS; Eun CS; Song KS; Kim YS; Chang SH; Shin HR; Kang D; Yoo KY; Park SK
    Int J Cancer; 2013 May; 132(9):2148-56. PubMed ID: 23001699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population.
    Sun L; Tu H; Liu J; Gong Y; Xu Q; Jing J; Dong N; Yuan Y
    Scand J Gastroenterol; 2014 Oct; 49(10):1164-72. PubMed ID: 25157583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of circulating VacA-neutralizing antibodies with gastric cancer and duodenal ulcer.
    Ayala G; Flores-Luna L; Hernández-Amaro D; Mendoza-Hernández G; Chihu-Amparán L; Bernal-Sahagún F; Camorlinga M; Lazcano-Ponce E; Torres J
    Cancer Causes Control; 2011 Oct; 22(10):1425-34. PubMed ID: 21779758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
    Li BS; Zhao YL; Guo G; Li W; Zhu ED; Luo X; Mao XH; Zou QM; Yu PW; Zuo QF; Li N; Tang B; Liu KY; Xiao B
    PLoS One; 2012; 7(7):e41629. PubMed ID: 22860003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.
    Kotiw M; Johnson M; Pandey M; Fry S; Hazell SL; Netter HJ; Good MF; Olive C
    Clin Vaccine Immunol; 2012 Feb; 19(2):268-76. PubMed ID: 22205658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.